Interestingly, when considering MYCN amplification across the entire cohort, high CNTN1 expression was associated with a significantly increased overall survival probability for neuroblastoma patients with non-MYCN-amplified tumors (Figure 2F). This evidence concerns the gene MYCN and neuroblastoma.